Trailing-twelve-month (TTM) revenue is $4.29 Billion with a year-over-year growth of +10.63%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,070,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-23 |
| Q4 FY2025Period ended 2025-12-31 | $1,033,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $1,033,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-28 |
| Q2 FY2026Period ended 2026-06-30 | $1,151,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-23 |
| TTM revenue | $4,288,500,000 |
Current P/S: $13,008,504,480 market capitalization ÷ $4,288,500,000 TTM revenue = 3.03x.
Market capitalization source: FMP quote. Quote observed 2026-09-24T18:40:17.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.15B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-24T18:40:31.415Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non Mechanical Product Revenues [Domain] | $574M | $618M | $112M | $192M | $254M | $278M |
| Product | $2.1B | $2.2B | $3.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Allegion International | N/A | $919M | $869M | $896M | $914M | $1.0B |
| Americas | $2.0B | $1.9B | $2.4B |
$4.29B
$4.29 Billion
+10.63%
vs. $3.88B a year ago (TTM)
+8.16%
5 Year compound annual growth rate
1 Year
+10.63%
3 Year
+5.90%
5 Year
+8.16%
10 Year
+7.02%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.07B | +$295.10M | +7.82% |
| 2024 | $3.77B | +$121.40M | +3.33% |
| 2023 | $3.65B | +$378.90M | +11.58% |
| 2022 | $3.27B | +$404.50M | +14.11% |
| 2021 | $2.87B | +$147.50M | +5.42% |
| 2020 |
TTM Growth
+10.63%
3-Year CAGR
+5.90%
5-Year CAGR
+8.16%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-24T18:40:31.415Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $3.5B |
| $3.8B |
| $2.9B |
| $3.0B |
| Asia Pacific | $149M | N/A | N/A | N/A | N/A | N/A |
|---|
| EMEIA | $555M | N/A | N/A | N/A | N/A | N/A |
|---|
| $2.72B |
| ($134.10M) |
| (4.70%) |
| 2019 | $2.85B | +$122.30M | +4.48% |
| 2018 | $2.73B | +$323.50M | +13.43% |
| 2017 | $2.41B | +$170.20M | +7.61% |
| 2016 | $2.24B | +$169.90M | +8.22% |
